Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
27.35
+0.36 (1.33%)
At close: Aug 7, 2026, 4:00 PM EDT
27.48
+0.13 (0.48%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Mineralys Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Maintains $49 → $42 | Buy | Maintains | $49 → $42 | +53.56% | Jun 4, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $44 → $54 | Buy | Reiterates | $44 → $54 | +97.44% | Jun 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $56 | Buy | Reiterates | $56 | +104.75% | Jun 1, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $48 | Buy | Maintains | $48 | +75.50% | May 19, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $52 | Buy | Maintains | $52 | +90.13% | May 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $55 | Buy | Maintains | $55 | +101.10% | Mar 14, 2026 |